Rentokil Initial Plc Stock Current Valuation
| RTOKYDelisted Stock | USD 32.79 0.40 1.21% |
Valuation analysis of Rentokil Initial PLC helps investors to measure Rentokil Initial's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Rentokil Initial's price fluctuation is very steady at this time. Calculation of the real value of Rentokil Initial PLC is based on 3 months time horizon. Increasing Rentokil Initial's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Rentokil Initial is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Rentokil Pink Sheet. However, Rentokil Initial's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 32.79 | Real 27.74 | Hype 32.79 | Naive 32.42 |
The intrinsic value of Rentokil Initial's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Rentokil Initial's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Rentokil Initial PLC helps investors to forecast how Rentokil pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Rentokil Initial more accurately as focusing exclusively on Rentokil Initial's fundamentals will not take into account other important factors: Rentokil Initial PLC Company Current Valuation Analysis
Rentokil Initial's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Rentokil Initial Current Valuation | 11.45 B |
Most of Rentokil Initial's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Rentokil Initial PLC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Rentokil Initial PLC has a Current Valuation of 11.45 B. This is 57.19% higher than that of the Industrials sector and significantly higher than that of the Specialty Business Services industry. The current valuation for all United States stocks is 31.14% higher than that of the company.
Rentokil Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Rentokil Initial's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Rentokil Initial could also be used in its relative valuation, which is a method of valuing Rentokil Initial by comparing valuation metrics of similar companies.Rentokil Initial is currently under evaluation in current valuation category among its peers.
Rentokil Fundamentals
| Return On Equity | 0.21 | |||
| Return On Asset | 0.0419 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.13 % | |||
| Current Valuation | 11.45 B | |||
| Shares Outstanding | 372.77 M | |||
| Shares Owned By Institutions | 0.84 % | |||
| Price To Earning | 37.07 X | |||
| Price To Book | 5.98 X | |||
| Price To Sales | 3.12 X | |||
| Revenue | 2.96 B | |||
| Gross Profit | 2.37 B | |||
| EBITDA | 656.6 M | |||
| Net Income | 263.2 M | |||
| Cash And Equivalents | 2.37 B | |||
| Cash Per Share | 6.38 X | |||
| Total Debt | 1.26 B | |||
| Debt To Equity | 2.64 % | |||
| Current Ratio | 1.88 X | |||
| Book Value Per Share | 3.87 X | |||
| Cash Flow From Operations | 563.2 M | |||
| Earnings Per Share | 0.80 X | |||
| Price To Earnings To Growth | 1.43 X | |||
| Target Price | 13.46 | |||
| Number Of Employees | 46 K | |||
| Beta | 0.44 | |||
| Market Capitalization | 9.6 B | |||
| Total Asset | 4.32 B | |||
| Retained Earnings | 2.07 B | |||
| Working Capital | (196 M) | |||
| Current Asset | 593 M | |||
| Current Liabilities | 789 M | |||
| Z Score | 4.2 | |||
| Annual Yield | 0.02 % | |||
| Five Year Return | 1.23 % | |||
| Net Asset | 4.32 B | |||
| Last Dividend Paid | 0.067 |
About Rentokil Initial Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Rentokil Initial PLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Rentokil Initial using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Rentokil Initial PLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Consideration for investing in Rentokil Pink Sheet
If you are still planning to invest in Rentokil Initial PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Rentokil Initial's history and understand the potential risks before investing.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |